Cargando…
Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
BACKGROUND: To minimise placental transfer of tumour necrosis factor inhibitors (TNFi), the European League Against Rheumatism (EULAR) created points to consider (PtC) for the use of TNFi during pregnancy. We are the first to validate the EULAR-PtC by analysing TNFi concentrations in cord blood. MET...
Autores principales: | Ghalandari, Nafise, Kemper, Erik, Crijns, Ineke (Hubertina), Wolbink, Gertjan, Rispens, Theo, Smeele, Hieronymus TW, Dolhain, Radboud JEM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862049/ https://www.ncbi.nlm.nih.gov/pubmed/34493490 http://dx.doi.org/10.1136/annrheumdis-2021-221036 |
Ejemplares similares
-
Active counselling and well-controlled disease result in a higher percentage of women with rheumatoid arthritis that breast feed: results from the PreCARA study
por: Kemper, Erik, et al.
Publicado: (2022) -
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance
por: Ghalandari, Nafise, et al.
Publicado: (2022) -
Therapeutic TNF Inhibitors can Differentially Stabilize Trimeric TNF by Inhibiting Monomer Exchange
por: van Schie, Karin A., et al.
Publicado: (2016) -
Immunogenicity of TNF-Inhibitors
por: Atiqi, Sadaf, et al.
Publicado: (2020) -
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
por: Krieckaert, Charlotte, et al.
Publicado: (2022)